Medical Spa Equipment Financing & Business Loans in Seattle, WA (2026)

Scan the guides linked below, find the one that matches your situation — startup, established clinic, equipment-only, or full acquisition — and follow that path. Everything on this page is orientation; the numbers and lender comparisons live in the guides.

What to know before you pick a financing path in Seattle

Seattle's medspa market is competitive. Clinics here are buying body-contouring platforms, picosecond lasers, and RF-microneedling devices that routinely cost $80,000–$250,000 per unit. That price range puts most deals squarely in structured financing territory — and the choice between equipment financing, an SBA loan, and a working capital line shapes your monthly cash flow for years.

Equipment financing (dedicated lenders) is the fastest path for a single device purchase. Approval runs 1–3 days, collateral is the equipment itself, and rates for borrowers at 700+ FICO typically fall in the 7–11% APR range with 10–20% down. Fair-credit borrowers (620–679 FICO) get approved at many of these lenders but pay 2–4 percentage points more and often put 20–30% down. The equipment secures the loan, so underwriting is lighter than a bank term loan. One frequently missed detail: origination fees of 1–3% are standard and should be folded into your total cost comparison.

SBA 7(a) loans make sense when you need more than one device, are financing a renovation alongside equipment, or are acquiring a practice. The ceiling is $5,000,000, terms stretch to 10 years for equipment and 25 years for real estate, and 2026 rates run 8.5–11% APR. The tradeoff is time: expect 30–45 days from a complete application to funding. The SBA guarantees up to 85% of the loan, which is why banks will take on medical-aesthetic borrowers who wouldn't qualify for a conventional term loan. Minimums to know: 640+ credit score, 24 months in business, and a debt service coverage ratio of at least 1.25x (your net operating income divided by annual debt payments).

Working capital lines and short-term loans cover payroll gaps, injectable inventory, and marketing spend between big device purchases. APRs on SBA-backed working capital run 8.5–11%; non-bank alternatives are faster but significantly more expensive. Merchant cash advances — sometimes pitched aggressively to clinics — carry an APR equivalent of 80–150% and should be a last resort, not a default. Seattle clinics managing Botox and filler supply-chain cash flow have more targeted options, including revolving credit structures built around injectable inventory cycles.

Section 179 is worth flagging for any Seattle clinic buying equipment before December 31: the 2026 deduction limit is $1,220,000, meaning you can expense the full cost of most devices in the year of purchase rather than depreciating over time. Confirm eligibility with your CPA before structuring a deal.

What trips people up in Seattle specifically:

• Washington has no state income tax, which simplifies some entity-level tax planning but doesn't change federal lending criteria.
• Lease vs. loan math: many device vendors push lease structures that look cheaper monthly but carry no ownership equity and higher total cost. Run a full lease-vs-finance comparison.
• Startup clinics (under 24 months) can't access SBA 7(a) programs. Equipment-only financing, SBA Microloans up to $50,000, or CDFI loans are the realistic options until you hit the two-year mark.
• Lenders reviewing your application will pull 12 months of bank statements. Inconsistent deposits — common in practices that opened recently or shifted service mix — can compress the loan amount you qualify for even if your credit score is strong.

The full breakdown of lender types, rate comparisons, and application checklists is at medspa equipment and startup financing options for Seattle practitioners. If you're outside Washington and comparing notes from other markets, the guides for Anchorage, AK and Anaheim, CA cover similar equipment-heavy clinic environments and can help you benchmark what lenders expect in different regulatory settings.